US IPO Week Ahead: Lung disease biotech and Bill Ackman deals set to debut
One IPO is currently scheduled for the week ahead, joined by Bill Ackman’s Pershing Square deals. Some smaller issuers may also join the calendar throughout the week. Pulmonary fibrosis biotech Avalyn Pharma (AVLN) is set to raise $201 million at a...read more



